Pre-operative use of levosimendan in two patients with severe aoric stenosis and left ventricular dysfunction

Heart Lung and Circulation

Volumn 15, Issue 1, 2006, Pages 56-58

  Prior, David L ^a   Flaim, Brendan D ^a   MacIsaac, Andrew I ^a   Yii, Michael Y ^a  

^a ST VINCENT S HOSPITAL   (Australia)

Author keywords

Aortic valve; Aortic valve surgery; Heart failure; Inotropic agents; Stenosis

Indexed keywords

CALCIUM SENSITIZER; FUROSEMIDE; LEVOSIMENDAN;

ADULT; AGED; AORTA STENOSIS; AORTA VALVE REPLACEMENT; ARTICLE; CASE REPORT; CORONARY ARTERY BYPASS SURGERY; CORONARY ARTERY DISEASE; DISEASE SEVERITY; DRUG DOSE REGIMEN; DRUG TOLERABILITY; DRUG USE; HEART FAILURE; HEART LEFT VENTRICLE FUNCTION; HIGH RISK PATIENT; HUMAN; HYPOTENSION; MALE; PERIOPERATIVE PERIOD; PREOPERATIVE PERIOD; PREOPERATIVE TREATMENT; PRIORITY JOURNAL; SURGICAL RISK;

EID: 33644831104     PISSN: 14439506     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.hlc.2005.03.008     Document Type: Article

References (8)

1. + channel in rat arterial myocytes. Eur J Pharmacol 1997;333:249-59.
2. Hasenfuss G, Pieske B, Castell M, Kretschmann B, Maier LS, Just H. Influence of the novel inotropic agent levosimendan on isometric tension and calcium cycling in failing human myocardium. Circulation 1998;98:2141-7.
3. Kivikko M, Lehtonen L, Colucci WS. Sustained hemodynamic effects of intravenous levosimendan. Circulation 2003;107:81-6.
4. Carabello BA, Stewart WJ, Crawford FA. Aortic valve disease. In: Topol EJ, editor. Textbook of cardiovascular medicine. Philadelphia: Lippincott-Raven; 1998. p. 533-55.
5. Khot UN, Novaro, GM, Popovic ZB, et al. Nitroprusside in critically ill patients with left ventricular dysfunction and aortic stenosis. N Engl J Med 2003;348:1756-63.
6. Nijhawan N, Nicolosi AC, Montgomery MW, Aggarwal A, Pagel PS, Warltier DC. Levosimendan enhances cardiac performance after cardiopulmonary bypass: a prospective, randomized placebo-controlled trial. J Cardiovasc Pharmacol 1999;34:219-28.
7. Follath F, Cleland JG, Just H, et al. Efficacy and safety of intravenous levosimendan compared with dobutamine in severe low-output heart failure (the LIDO study): a randomised double-blind trial. Lancet 2002;360:196-202.
8. Kloner RA, Jennings RB. Consequences of brief ischemia: stunning, preconditioning, and their clinical implications: Part 2. Circulation 2001;104:3158-67.